The Alzheimer's disease market involves a range of players, including pharmaceutical companies, research institutions, advocacy organizations, and healthcare providers, all contributing to research, development, diagnosis, treatment, and support for individuals affected by the disease.

To gain more information about the Alzheimer’s Disease market forecast, download a free report sample

Here are some key players and brands shaping the Alzheimer's disease market:

1. Pharmaceutical Companies:

   • Biogen: Biogen is a leading biotechnology company involved in Alzheimer's disease research and development. The company's investigational drug aducanumab, targeting amyloid-beta plaques, has been a focal point in Alzheimer's drug development.
   • Eli Lilly and Company: Eli Lilly is engaged in Alzheimer's disease research and has developed drugs such as solanezumab and donanemab, targeting amyloid-beta aggregation and tau protein pathology.
   • Roche (Genentech): Roche, through its subsidiary Genentech, is actively involved in Alzheimer's disease research and has developed investigational drugs such as gantenerumab, crenezumab, and semorinemab targeting amyloid-beta and tau.
   • Novartis: Novartis is pursuing Alzheimer's disease research and has collaborations with other companies to develop novel therapeutics targeting various aspects of the disease pathology.

2. Research Institutions and Academic Centers:

   • National Institute on Aging (NIA): NIA, part of the National Institutes of Health (NIH), supports Alzheimer's disease research through funding, clinical trials, and collaborative initiatives.
   • Alzheimer's Disease Neuroimaging Initiative (ADNI): ADNI is a longitudinal multicenter study aimed at identifying biomarkers for Alzheimer's disease progression using neuroimaging, genetics, and clinical assessments.
   • Banner Alzheimer's Institute: Banner Alzheimer's Institute conducts clinical trials, research, and provides patient care, with a focus on early detection and prevention of Alzheimer's disease.

3. Advocacy Organizations and Nonprofits:

   • Alzheimer's Association: The Alzheimer's Association is a leading nonprofit organization dedicated to Alzheimer's disease advocacy, awareness, support, and research funding.
   • Alzheimer's Research UK: Alzheimer's Research UK is the largest dementia research charity in the UK, funding research into the prevention, treatment, and cure of Alzheimer's disease and other dementias.
   • UsAgainstAlzheimer's: UsAgainstAlzheimer's is an advocacy organization focused on accelerating research, engaging diverse communities, and advocating for policies to combat Alzheimer's disease.

4. Diagnostic Companies:

   • Cognetivity Neurosciences: Cognetivity Neurosciences develops digital cognitive assessment tools for early detection and monitoring of Alzheimer's disease and other cognitive impairments.
   • C2N Diagnostics: C2N Diagnostics develops cerebrospinal fluid (CSF) and blood-based biomarker tests for Alzheimer's disease diagnosis and monitoring.
   • Lumosity: Lumosity offers brain-training games and cognitive assessments that may help individuals monitor and maintain cognitive function.

5. Caregiver Support and Services:

   • Alzheimer's Foundation of America (AFA): AFA provides support services, resources, and educational programs for individuals living with Alzheimer's disease and their caregivers.
   • Caregiver Action Network (CAN): CAN offers support, advocacy, and resources for family caregivers, including those caring for individuals with Alzheimer's disease and other forms of dementia.

These key players and brands play essential roles in advancing research, innovation, advocacy, and support for individuals affected by Alzheimer's disease and their families. Collaboration among stakeholders is critical for addressing the challenges posed by Alzheimer's disease and improving outcomes for those living with the condition.